News – SFL Regulatory Affairs & Scientific Communication Ltd.

Shayesteh Fürst-Ladani, CEO of SFL, has been invited to give a key note speech at GPKOL (Global Pharma Key Opinion Leader) about European regulatory affairs with special focus on Orphan and Advanced Therapy Medicinal Products. GPKOL will take place during Bio Korea on 13 April 2017 in COEX Center in Seoul, South Korea. In her speech, Shayesteh […]

29. March 2017

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland, where she meets with top regulators and industry professionals in the development of drugs, devices and combination products. Shayesteh joins the entire conference from 29 to 31 March, representing SFL, a leading consultancy company providing integrated solutions in the […]

9. March 2017

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017. As a leading consultancy company providing integrated solutions in the areas of Regulatory Affairs, Medical Affairs, Public Affairs, Legal, Pharmacovigilance, Quality Assurance and Reimbursement, SFL is an ideal partner to support companies interested in bringing their products to the market or supporting […]

SFL authors article in RAPS on pathways for innovative medicines in Switzerland

SFL’s CEO presented at the Rare Disease Action Forum workshop

SFL’s Quality Assurance experts presented at Basel Area webinar on biotech

SFL’s CEO presented at the Medtech & Pharma platform Association’s (MPP’s) training on connected combined products

SFL training course on Swiss regulatory and reimbursement pathways for medicines

SFL’s CEO will take part in the Medtech & Pharma platform Association’s (MPP’s) upcoming training course on connected combined products

SFL’s Senior Manager Regulatory Affairs presents at the Bulgarian Association for Drug Information (BADI) event

SFL is named the 3rd best place to work amongst small companies in Switzerland

SFL’s team members will present at the Medtech & Pharma Platform training on clinical evaluation on 26 May

SFL’s CEO presented regulatory and market access perspectives in Switzerland at Swiss Business Hub UK & Ireland webinar

SFL hosted a webinar jointly with Swiss Medtech on combined products

SFL organizes a training course on Swiss regulatory affairs and reimbursement pathways on 9 June

SFL’s CEO presents at KHIDI webinar on GxP inspections

SFL participates in [MEET THE EXPERT] Implants

SFL’s CEO presented at the joint MPP / UK DIT webinar

SFL’s CEO will present at the joint MPP / UK DIT webinar

SFL will host a joint webinar with Swiss Medtech on combined products on 11 May 2021

SFL certified a Great Place to Work® in Switzerland

SFL’s CEO will present perspectives about the future of EMA at the DIA Europe 2021

SFL virtual training on GDP requirement of the Swiss Establishment License on 11 February

SFL receives EU Commission approval for the orphan medicinal product “Obiltoxaximab SFL”

SFL participates in the 50th EMWA conference

The SFL team is at MPP2020

SFL to chair session on developing innovative products at the MPP2020 virtual conference

SFL’s CEO to moderate panel discussion on MDR and combined products

SFL’s CEO to present at lunch webinar on MDR and combined products

SFL to present on supply chain and EU regulation at the MPP2020 virtual conference

SFL’s Head of Medical Devices provides Medical Devices Regulation (MDR) training focused on combination products

SFL to present on regulations in digital health at expert event

SFL marketing authorization application for the orphan medicinal product “Obiltoxaximab SFL” receives CHMP positive option

SFL to participate at Swiss Medtech Day

SFL to lead breakout session at MDR & IVDR online conference

SFL is participating in the Biotechgate digital partnering event

European Commission publishes evaluation of the legislation on medicines for children and rare diseases

SFL’s Head of Medical Devices to give MDR webinar on interacting with Notified Bodies

SFL CEO awarded Global Fellow in Medicines Development

SFL CEO to co-chair DIAmond regulatory session at DIA Europe 2020 meeting

SFL CEO to chair medical device session at DIA Europe 2020 meeting

Visit the SFL Booth at DIA Europe 2020 meeting

SFL is participating in the DIA 2020 Global Annual Meeting with a virtual booth

SFL is participating in the BIO Digital International Convention

SFL supported first Swiss approval of an oncology drug in line with US FDA’s Project Orbis; an initiative for concurrent submission and review of oncology drug applications by US FDA and international regulatory agencies

SFL to present free webinar on prerequisites before launching drug products in Switzerland

SFL to present free webinars on obtaining drug regulatory approval in Europe

SFL CEO to chair medical device session at DIA Europe 2020 meeting (DIA meeting postponed, SFL will follow updates)

Visit the SFL Booth at DIA Europe 2020 meeting (DIA meeting postponed, SFL will follow updates)

SFL’s device experts provide training focused on MDR implementation for medical devices and combination products

SFL to participate in EU pharma and medical device law conference

SFL’s CEO invited to speak on disruptive healthcare technologies at the Swiss HLG Winter Conference

Brexit goes real – What’s next for Pharma and Medtech

SFL to present free webinar on the EU Orphan Drug Designation Regulations today

SFL’s Head of Medical Devices is lecturing on medical device vigilance at FHNW

SFL’s Senior Market Access Manager attends the BMC Congress 2020

SFL publishes article on regulatory approval of software and digital healthcare devices

SFL invites you to a free webinar on Orphan Drug Designation Application in the EU 30 January 2020, 4 – 5 pm CET

SFL’s Head of Public Affairs and Regulatory Policy is presenting on Swiss Regulation of Therapeutic Products at Bonn University

MDR and IVDR corrigenda set for approval

SFL attends the 8th EBE ATMP conference

MPP2019 Annual Meeting Report published in MedNous

SFL team provides Medical Devices Regulation (MDR) training focused on combination and substance-based products

SFL publishes report on combination products from the recent TOPRA conference

SFL to present free webinar on the revised Swiss Regulations for Medicinal Products (TPA)

Registration is open for Medical Devices Regulation (MDR) training focused on combination and substance-based products

SFL offers on 28 November 2019 a 1-hour free webinar on the Revised Swiss Therapeutic Products Act & Ordinances

SFL’s Head of Combination Products presents an introductory training on the Medical Devices Regulation (MDR)

SFL to attend the Swissmedic Regulatory News Seminar

SFL participates in the 49th EMWA conference

SFL attends the CPhI Worldwide exhibition

SFL’s Senior Market Access Manager to participate in ISPOR Europe 2019

SFL attends the BioAlps Networking Day 2019

SFL kicks off the 6th Medtech & Pharma Platform Annual Conference in Basel

SFL’s Head of Combination Products Theresa Jeary to lead workshop about the medical device industry

SFL’s Senior Market Access Manager attends the BMC annual reception

SFL’s Head of Combination Products attend 2019 TOPRA symposium

SFL attends the 2019 IVD Regulatory Conference

SFL to meet European Commissioner and participate in the EU policy event

SFL’s Head of Combination Products Theresa Jeary to present training on the Medical Devices Regulation (MDR)

SFL attends event on Clinical trial strategy

SFL attends the 2019 DayOne Conference focusing on precision medicine and digital health

SFL is a Data Expert at the 3rd Swiss Digital Day’s Data Café

European Commission to consider amending EU-MDR to extend Class Ir compliance deadline beyond May 2020

SFL attends the 6th Swiss-Korean Life Science Symposium

SFL’s Head of Combination Products Theresa Jeary to present introductory trainings on the Medical Devices Regulation (MDR) and combination products

The new European Parliament committees at the heart of EU policy making, and implications for the healthcare sector

SFL’s Head of Supply Chain to attend 2019 edition of Temperatuz in Barcelona

SFL to present free webinar on the MDR Updates and Article 117 for Combination Products

SFL’s Head of Medical Devices to attend Swiss Medtech morning talk at CICOR

SFL to participate at the DIA 2019 Global Annual Meeting

Registration is open for the next training course on the Medical Devices Regulation (MDR)

SFL to attend Swiss Medtech Day

SFL participating in BIO International Convention

SFL is attending an event on MDR/IVDR 2020 readiness

SFL is at Swiss Startup Day 2019

First insights into the European Parliament 2019 elections: impact on the healthcare sector

SFL’s Senior Market Access Manager to attend discussion on AMNOG and the evaluation of new pharmaceuticals in Germany

SFL’s Head of Combination Products Theresa Jeary to present workshop on the medical device industry

SFL’s Head of Combination Products Theresa Jeary to present an introductory training on the Medical Devices Regulation (MDR)

SFL with booth at the Lausanne Life Science Career Day

SFL participates in the 48th EMWA conference

SFL attends the Swiss Biotech Day 2019

SFL to attend conference on the changing IP landscape in the EU

SFL presents at the BIOPÔLE

SFL publishes impact assessment article in European Pharmaceutical Law Review

SFL’s Senior Market Access Manager to participate at the Annual Conference of the SGV/SSMC

SFL to speak at the Swiss Medtech IVDR&MDR Conference

SFL participates in the MHRA Clinical Pharmacokinetics Masterclass

SFL to participate in discussions on the FDA’s approach to software as medical devices

Registration is open for the next training course on the Medical Devices Regulation (MDR)

SFL to participate in the annual DGGO conference

SFL to participate at the opening of BIOPÔLE Digital Health Hub

SFL’s Senior Market Access Manager to moderate discussion panel on cross-sectoral care

SFL celebrates its 10th anniversary

Is legislation on rare diseases in Germany taking a blind alley?

SFL to participate in “Zürich meets Basel” meeting dedicated to digital health

SFL exhibits at DIA Europe 2019

SFL is sponsoring the “Jungunternehmerpreis Nordwestschweiz 2018” (Young Entrepreneur Award)

SFL participates in CMS Global Life Sciences & Healthcare Forum

SFL is opening a new office in Lausanne

SFL attends Sidley Austin’s event on IP law in Brussels

SFL to exhibit at the SwAPP/SGPM annual meeting

SFL attends Swissmedic info days

SFL to participate in the BaselArea.swiss event on cybersecurity for medical devices

Meet SFL at the next DayOne Experts event

Medtech & Pharma Platform annual event celebrates its 5th anniversary in Basel

SFL Pharma participates in Lamprecht Pharma Logistics Day

SFL attends MDR Readiness Day

SFL Pharma to attend BaselArea’s “European-Chinese Pharma Partnering” event

SFL attends Swiss Biotech Day Fall 2018

SFL participates in Morning Talk at Johnson & Johnson

SFL to attend 1st Conference of the Swiss Society of Health Economics (SGGÖ)

Swiss Association for Quality: SFL is attending the medical devices expert group meeting

SFL to exhibit at the RAPS Regulatory Convergence 2018

SFL attends life science event organized by the British-Swiss Chamber of Commerce

Registration is open for the next training course on the Medical Devices Regulation (MDR)

SFL invited to give keynote speech on CE certification of medical devices

Potential Brexit impact on the conduct of clinical trials

SFL will speak at SAQ’s medical products expert group meeting

SFL is attending an event on harmonization of European health technology assessments (HTAs)

SFL exhibits at BIOtech Japan

SFL participating in BIO International Convention

SFL to attend first Basel Pharma Technical Innovation Forum

SFL – A Great Place to Work® in Switzerland

SFL will attend event on artificial intelligence

SFL sponsors the Basel Postdoc Network Retreat 2018

SFL to exhibit at the Swiss Medtech Day

SFL attends Swiss Biotech Day 2018

SFL to attend event on compliance and health

Life Science Career Day in Lausanne: career options in medical affairs and regulatory affairs in a consultancy setting

SFL attends the 2018 China/EU Pharmaceutical Industry Forum

SFL to chair a symposium on psychiatric care

SFL presents and exhibits at DIA Europe 2018

SFL to speak in Swiss MDR/IVDR Forum

Additional presentation of the training course on the Medical Devices Regulation (MDR)

SFL participates in MHRA Variations Masterclass and Workshop

SFL attends [MEET THE EXPERT] Implants event

Medical Devices: expected bottlenecks for certification

Meet SFL at the 11th SwAPP ExEx meeting

SFL will speak at Swiss Medtech’s MDR & IVDR conference

SFL attends DayOne Experts event in Basel

Meet SFL at the annual conference of the German Health Economics Association

SFL to attend the Rare Disease Day organized by ProRaris

SFL attends Sidley Austin’s life sciences law event in Brussels

Meet SFL at the BaselArea.swiss event on the new MDR and IVDR

SFL attends FutureHealth Basel

Medtech & Pharma Platform 2018 – Call for abstracts now open

SFL to join Swiss Medtech’s Swiss Implementation Taskforce (SIT) discussion group

Registration is open for the next training course on the Medical Devices Regulation (MDR)

SFL attends Swissmedic annual event

“Combination products: highly innovative, but complex”

Successful 4th Medtech & Pharma Platform 2017

Interview of SFL CEO Shayesteh Fürst-Ladani by Swiss Embassy

Meet us at the RAPS 2017 (Booth 604), 9-12 Sep 2017, Washington DC

CEO of SFL invited to speak about Strategies for Interacting With Global Regulatory Agencies at Biotech NetWorkshop in Munich, Germany

CEO of SFL invited to speak about European Orphan and Advanced Therapy Medicinal Products Regulations at GPKOL, South Korea

Shayesteh Fürst-Ladani, CEO of SFL, has been invited to give a key note speech at GPKOL (Global Pharma Key Opinion Leader) about European regulatory affairs with special focus on Orphan and Advanced Therapy Medicinal Products. GPKOL will take place during Bio Korea on 13 April 2017 in COEX Center in Seoul, South Korea. In her speech, Shayesteh […]

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland, where she meets with top regulators and industry professionals in the development of drugs, devices and combination products. Shayesteh joins the entire conference from 29 to 31 March, representing SFL, a leading consultancy company providing integrated solutions in the […]

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017. As a leading consultancy company providing integrated solutions in the areas of Regulatory Affairs, Medical Affairs, Public Affairs, Legal, Pharmacovigilance, Quality Assurance and Reimbursement, SFL is an ideal partner to support companies interested in bringing their products to the market or supporting […]